OGEN - Oragenics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development5,971.8333,539.6564,754.658,733.51
Selling General and Administrative4,022.3073,178.6623,787.8553,047.354
Non Recurring----
Others1.1883.0984.7984.7
Total Operating Expenses9,995.3286,721.4168,547.30311,785.564
Operating Income or Loss-9,995.328-6,721.416-8,547.303-11,785.564
Income from Continuing Operations
Total Other Income/Expenses Net81.187-10.10949.987-5,054.514
Earnings Before Interest and Taxes-9,995.328-6,721.416-8,547.303-11,785.564
Interest Expense-5.786-216.328-4.116-76.668
Income Before Tax-9,914.141-6,731.525-8,497.316-11,840.078
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-9,914.141-6,731.525-8,497.316-11,840.078
Non-recurring Events
Discontinued Operations--1,484.012128.745
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-9,914.141-6,731.525-7,013.304-11,711.333
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-11,326.182-6,731.525-7,013.304-11,711.333